HIND

VYOME HOLDINGS INC

HIND·92943X104·US·Common Stock·Healthcare - Biotechnology

HIND (VYOME HOLDINGS INC) is held by 10 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($55,840), GEODE CAPITAL MANAGEMENT, LLC ($55,454), Focus Partners Wealth ($31,476). Net institutional sentiment: Mixed.

10
Holders
$249,660
Total Value
67% (6)
Consensus
4 buying - 2 selling
13F: Insider & Congress: Updated regularly
HIND

Smart Money Verdict

View all
Loading verdict
Held by 10 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for HIND.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
25,972$55,8400.0%+2.56%
32
Unchanged
25,793$55,4540.0%-32.64%
0
Unchanged
14,640$31,4760.0%-35.90%
0
Unchanged
12,195$26,2190.0%-29.55%
0
Decreased
11,908(-47.5%)$25,6020.0%-31.33%
0
New
10,058$21,6250.0%+2.56%
29
Unchanged
9,463$20,3450.0%-29.55%
0
Unchanged
5,856$13,0000.0%-58.86%
0
New
26$560.0%+2.56%
17
New
20,318$430.0%+2.56%
15
Exited
0(-100.0%)$340.0%-31.73%
0
HINDHINDVYOME HOLDINGS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used